Phase 1 Study of EGFR-Antisense DNA, Cetuximab, and Radiotherapy in Head and Neck Cancer With Preclinical Correlatives

BACKGROUND: Cetuximab combined with radiation therapy (RT) is an evidence-based treatment for locally advanced head and neck squamous cell carcinoma (HNSCC); however, locoregional failure remains the primary cause of cancer-related death in this disease. Intratumoral injection of epidermal growth fa...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer
Auteurs principaux: Bauman, Julie E., Duvvuri, Umamaheswar, Thomas, Sufi, Gooding, William E., Clump, David A., Karlovits, Brian, Wehbe, Ahmad, Miller, Frank R., Kim, Seungwon, Sen, Malabika, Heron, Dwight E., Grandis, Jennifer R., Argiris, Athanassios
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6521720/
https://ncbi.nlm.nih.gov/pubmed/30291796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.31651
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires